EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 199 filers reported holding EDITAS MEDICINE INC in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,430 | -5.2% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $15,229 | +13.5% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,414 | +688.1% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,702 | -99.9% | 1,850 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,468,000 | -39.3% | 1,850 | -14.0% | 0.01% | -33.3% |
| Q2 2022 | $4,067,000 | -0.3% | 2,150 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $4,081,000 | -49.2% | 2,150 | 0.0% | 0.01% | -50.0% |
| Q4 2021 | $8,033,000 | -0.4% | 2,150 | 0.0% | 0.02% | -5.3% |
| Q3 2021 | $8,062,000 | -53.0% | 2,150 | -37.7% | 0.02% | -52.5% |
| Q2 2021 | $17,170,000 | +34.8% | 3,450 | -5.5% | 0.04% | +17.6% |
| Q1 2021 | $12,740,000 | -40.1% | 3,650 | -2.7% | 0.03% | -41.4% |
| Q4 2020 | $21,274,000 | +7.9% | 3,750 | +7.1% | 0.06% | +544.4% |
| Q3 2020 | $19,720,000 | -5.2% | 3,500 | -2.8% | 0.01% | -25.0% |
| Q2 2020 | $20,791,000 | -80.5% | 3,600 | -75.5% | 0.01% | -83.6% |
| Q1 2020 | $106,394,000 | – | 14,688 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |